Lyophilized Sterile Vial
Tested: 99.4%
Current Lot: MV-2026-BPC20-08
High-Purity Lyophilized Peptide
BPC-157 Pentadecapeptide
20mg / 5mL Lyophilized • HPLC Purity: 99.4% • Target: ≥ 99.0%
BPC-157 (bepecin) is a synthetic linear 15-amino-acid pentadecapeptide investigated in preclinical models of tissue injury, inflammation, vascular signaling, and musculoskeletal repair.
Wholesale Commercial Pricing
Verified Provider Portal Required
• No consumer checkout • Tiered volume schedules • Certificate included with shipment
Formula C62H98N16O22
Molecular Weight 1419.5 g/mol
CAS Registry # 137525-51-0
Peptide Sequence / Structure GEPPPGKPADDAGLV
Current Lot Verification
Historical Lot Archive → Lot #MV-2026-BPC20-08 Analytical Results
Independent laboratory testing panel for active distribution batch.
| Analysis Category | Reported Result | Analytical Method | Verification Status |
|---|---|---|---|
| Purity (RP-HPLC) | 99.4% | High Performance Liquid Chromatography | Conforms |
| Identity (LC-MS) | 1419.6 Da | Mass Spectrometry (ESI-MS) | Conforms |
| Net Peptide Content | 20.12 mg | Quantitative Nitrogen / UV | Conforms |
| Bacterial Endotoxin | < 0.05 EU/mg | LAL Kinetic Turbidimetric | Conforms |
| Sterility Confirmation | No growth (14d) | USP <71> Membrane Filtration | Conforms |
Biological Mechanism of Action
Preclinical research demonstrates involvement in nitric oxide synthase (eNOS) modulation, VEGFR2 upregulation, focal adhesion kinase phosphorylation, and growth hormone receptor expression in tendon fibroblasts.
Research Focus Areas: Tissue Integrity Vascular Signaling Preclinical Gastric Models
Scientific Literature Cross-Reference
Explore primary peer-reviewed papers, PubMed indexes, and pharmacology data for BPC-157.